Most NMIBC Recurrences Seen in BCG-Exposed Patients

Published Date: 07 May 2026

A large real-world study examines outcomes and treatment patterns among patients with non-muscle-invasive bladder cancer treated with BCG.

Read Full News

Latest News

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Saturated Fat Tied to Worse Survival After Prostate Cancer

The association is driven by higher rates of death from cardiovascular disease and other cancers over 13 years.

Medication Self-Injection Embraced by Breast Cancer Patients

Women with breast cancer show interest in self-injecting their medication.

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

The oral HER2 TKI was previously given accelerated approval in the second line for the indication.

Latest News

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

The association is driven by higher rates of death from cardiovascular disease and other cancers over 13 years.

Women with breast cancer show interest in self-injecting their medication.

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

News All Time

Are Microplastics Feeding Cancer Risk?

Microplastics are everywhere, in the environment and the human body. But as public concern about possible health effects grows, evidence of a cancer connection remains thin.

Does Maintenance Therapy Extend Life in mCRC?

Maintenance therapy is linked to longer overall survival after first-line bevacizumab-based combination chemotherapy in patients with metastatic colorectal cancer, a study finds.

Preschoolers With Cancer Have Poor Motor Skills

Preschool children newly diagnosed with cancer exhibit significant motor impairments, reduced mobility, and weak grip strength at diagnosis, study shows.

Breast Cancer Survivors: Who Benefits From Weight-Loss Meds?

The oral drug naltrexone-bupropion helps some breast cancer survivors lose weight.

Fixed-Duration Combo Shows Promise for Relapsed MCL

Researchers examine the efficacy of fixed-duration mosunetuzumab plus polatuzumab vedotin in patients with heavily pretreated relapsed/refractory mantle cell lymphoma.

US Cancer Trials Heavily Favor Single Drugs Over Care Issues

Industry trials focus on single drugs, while publicly funded trials often look at broader cancer care. It’s a ‘complementary’ approach, but pharma enrolls over 90% of patients.

Ruxolitinib Reduces Acute GVHD in Transplant Patients

A phase 3 trial evaluates a low-dose ruxolitinib-based regimen for graft-vs-host disease prophylaxis among patients undergoing haploidentical hematopoietic stem-cell transplantation.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

NPM1-Mutated AML: Not All Treatments Are Equal

Researchers conducted a retrospective analysis of patients with newly diagnosed NPM1-mutated AML treated with high- or low-intensity regimens.

Transgender Individuals Prefer HPV Self-Swabs

Transgender and gender-diverse individuals prefer self-collected HPV testing for cervical cancer screening, a new survey shows.

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

In myelofibrosis, combinations of rufolitinib reduce spleen volume.

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

3.

Prostate Cancer Treatment Associated With Long-Term Complications

4.

Investigating the Relationship Between GERD and Anxiety/Depression.

5.

When Should Immunocompromised Individuals Receive a COVID Booster?

1.

The Ins and Outs of Glossectomy: What You Need to Know

2.

Exploring the Unknown: Unveiling the Mysteries of GIST Tumors

3.

Comprehensive Standards in Oncology for Modern Medicine

4.

Uncovering the Mysteries of Breast Cancer: The Journey to a Cure

5.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

4.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

5.

Navigating the Complexities of Ph Negative ALL - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Most NMIBC Recurrences Seen in BCG-Exposed Patients

Latest News

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

Talc Powder Not Linked to Lung Cancer in Women

Saturated Fat Tied to Worse Survival After Prostate Cancer

Medication Self-Injection Embraced by Breast Cancer Patients

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

Todays Updates

Sevabertinib Approved for First-Line Mutated NSCLC

Latest News

News All Time

Are Microplastics Feeding Cancer Risk?

Does Maintenance Therapy Extend Life in mCRC?

Preschoolers With Cancer Have Poor Motor Skills

Breast Cancer Survivors: Who Benefits From Weight-Loss Meds?

Fixed-Duration Combo Shows Promise for Relapsed MCL

US Cancer Trials Heavily Favor Single Drugs Over Care Issues

Ruxolitinib Reduces Acute GVHD in Transplant Patients

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

How Much of a Cancer Drug Is Too Much?

Belgian Algorithm Reshapes Endometrial Cancer Care

NPM1-Mutated AML: Not All Treatments Are Equal

Transgender Individuals Prefer HPV Self-Swabs

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

FDA Approves Iberdomide Combo for Multiple Myeloma

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Wide Variation Seen in Lung Screening False-Positive Rates

Recommended News For You

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

In women with extremely dense breasts, elevated MRI enhancement can help identify cancer risk.